Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

NCT03282370 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

655

Enrollment

OTHER

Sponsor class

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL: JEVAX
BIOLOGICAL: JECEVAX

Sponsor

National Institute of Hygiene and Epidemiology, Vietnam

Collaborators

[object Object]
[object Object]